肝硬化患者临床输血合理性分析

发布时间：2018-10-26 17:03

【摘要】：【目的】探讨肝硬化病例的临床特征和输血状况并分析其合理性。【方法】自行设计调查表,收集所有新入院肝硬化病例一般情况、临床特征、血液输注情况,以及吸烟、饮酒等生活行为习惯,并进行随访。【结果】共收集198例肝硬化病例,其中34.8%(69/198)的病例在住院期间输注了不同种类的血液品种,合计输血371次,其中52.2%的输血病例(36/69)在住院期间输注过2种及以上血液。69例输血肝硬化病例中,首次血液输注以治疗和预防为目的的病例分别为11例和58例;18例输注红细胞,输注总量为90.5 U。INR1.3的110例肝硬化病例中,分别有54.55%(60/110)、60.91%(67/110)未输注新鲜和冰冻血浆,而在INR≤1.3的病例中有2.27%(2/88)的病例输注了血浆。纤维蛋白原小于1.0 g/L的病例中,输注冷沉淀的病例占29.41%(5/17);大于1.0 g/L的病例中,输注冷沉淀的病例占3.87%(7/181)。【结论】血液输注是肝硬化患者较常用的治疗手段,经验性和预防性输血较普遍,应采取更科学的限制性输血策略以优化输血治疗方案。
[Abstract]:[objective] to investigate the clinical characteristics and blood transfusion status of patients with liver cirrhosis and analyze their rationality. [methods] A self-designed questionnaire was designed to collect the general, clinical features, blood transfusion and smoking of all the newly admitted patients with cirrhosis. [results] A total of 198 cases of liver cirrhosis were collected. 34.8% (69 / 198) of the cases received different kinds of blood transfusion during hospitalization, and 371 blood transfusions were made. Among them, 52.2% (36 / 69) of blood transfusion cases (36 / 69) had been infused with 2 or more kinds of blood during hospitalization. Among 69 cases of cirrhosis of blood transfusion, 11 cases were treated with the first blood transfusion and 58 cases were treated with prevention. Among 18 cases of liver cirrhosis, 54.55% (60 / 110) and 60.91% (67 / 110) were not infused with fresh or frozen plasma respectively. Plasma was injected in 2.27% (2 / 88) of patients with INR 鈮，

本文编号：2296405